New Research Uncovers Molecular "Firing Squad" Through Which Overeating Destroys Normal Metabolism And Sets Stage For Diabetes

February 5th, 2010 admin
Share/Save/Bookmark

Add To Delicious Digg This post Stumble this post
Topics:

Overeating in mice triggers a molecule once considered to be only involved in detecting and fighting viruses to also destroy normal metabolism, leading to insulin resistance and setting the stage for diabetes…


Originally posted on MedicalNewsToday

 
  Related Posts
Overeating Triggers Molecular ‘Firing Squad’ In Mice, Destroys Metabolism
Overeating in mice triggers a molecule once considered to be only involved in detecting and fighting viruses to also destroy normal metabolism, leading to insulin resistance and setting the stage for diabetes…  Read More →
Mice With High-Altitude Metabolism Stay Slim And Healthy On A High-Fat Diet
Mice that are missing a protein involved in the response to low oxygen stay lean and healthy, even on a high-fat diet, a new study has found. “They process fat differently,” said Randall Johnson, professor of biology at the University of California, San Diego, who directed the research, which is published in the April 15 issue of the journal... 
Oramed Pharmaceuticals Announces Publication Of Research Article On Its Oral Insulin Capsule ORMD-0801 In Diabetes, Obesity And Metabolism
Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, announced that the paper entitled, “Open-label study to assess the safety and pharmacodynamics of five oral insulin formulations in healthy subjects,” authored by Dr. Roy Eldor, Dr. Miriam Kidron and Dr. Ehud Arbit, was accepted and published... 
Genetic Variations Associated With Development Of End-Stage Kidney Disease In Chinese Patients With Diabetes
Examination of a gene involved in cell signaling finds that four common variants of this gene are associated with the development of end-stage renal disease in Chinese patients with type 2 diabetes, according to a study in the August 25 issue of JAMA. Renal (kidney) failure is an important cause of death among patients with type 2 diabetes…  Read More →
Master Regulator Discovery In Cell Metabolism, Response To Stress, Could Impact Obesity, Diabetes And Cancer Research
AMP-activated protein kinase, or AMPK, is a master regulator protein of metabolism that is conserved from yeast to humans. When a cell is low on fuel, AMPK shuts down processes that use energy and turns on processes that produce energy…  Read More →
Fast Forward, Juvenile Diabetes Research Foundation And Axxam SpA Join Forces To Develop Treatments For Multiple Sclerosis And Type 1 Diabetes
Fast Forward, LLC, the commercial drug development arm of the National Multiple Sclerosis Society, and the Juvenile Diabetes Research Foundation (JDRF), the leader in research leading to a cure for type 1 diabetes in the world announced a collaborative partnership with Axxam SpA — a leading company in conducting early-stage discovery research... 
Role Of Protein Pair In Obesity Regulation Highlighted By Research
New research by University of Cincinnati (UC) scientists implicates a new protein in obesity development and highlights a protein pair’s “team effort” in regulating obesity and insulin resistance. Jorge Moscat, PhD, chair of UC’s cancer and cell biology department, says that proteins p62 and ERK are involved in adipogeneis,... 
Cetero Research Announces More Than 500 Diabetes Studies Completed
Cetero Research, the leading early-stage contract research organization (CRO), announced it has completed more than 500 diabetes research studies in the past three years for both Type 1 and Type 2 diabetics, including complex clamp studies and studies in Phase I, II, III and IV…  Read More →
Overeating Prompts More Weight Gain in Diabetes-Prone People
People who have a family predisposition to Type 2 diabetes may be more likely to gain weight after overeating than those without a family diabetes link.  Read More →
Scientists Find Unsuspected Molecular Link Between Obesity And Insulin Resistance
A new understanding of insulin resistance and the action of diabetes drugs such as Avandia and Actos could pave the way for improved medications that are more selective and safer, say scientists from Dana-Farber Cancer Institute and The Scripps Research Institute…  Read More →
  Related Tweets from Twitter
  Related News from Digg

Spam Protection by WP-SpamFree

TOP